Johns Hopkins University Bloomberg School of Public Health
Efavirenz-based initial therapies associated with better outcomes in HIV-infected adults
Published in AIDS Weekly, November 10th, 2008
A study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that HIV-infected patients taking the antiretroviral drug efavirenz were more likely to adhere to treatment and less likely to experience virologic failure and death compared to patients taking nevirapine. Nevirapine is the most frequently prescribed drug for patients undergoing highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS in sub-Saharan Africa, where the study was conducted. The study is published in the October 18, 2008 issue of the journal AIDS.
"Our findings add to existing limited evidence that efavirenz-based therapies produce a more favorable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-11-10)
More Articles from AIDS Weekly
- Epstein-Barr Virus
Researchers from University of Pennsylvania provide details of new studies and findings in the area of Epstein-Barr virus - HIV/AIDS Co-Infection
Data from C.E. French et al provide new insights into HIV/AIDS co-infection - HIV/AIDS Co-Infection
Findings from M.L. Grijsen and co-researchers advance knowledge in HIV/AIDS co-infection - HIV/AIDS Co-Infection
New findings from University of London in the area of HIV/AIDS co-infection published - HIV/AIDS Co-Infection
Reports outline HIV/AIDS co-infection study findings from C.G. Meyer and colleagues - HIV/AIDS Co-Infection
Research from D.A. Lewis and co-researchers provides new data on HIV/AIDS co-infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
